Childhood Non-Hodgkin Lymphoma — Trials

Childhood Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 9
Recruiting: 5
Ph III recruiting: 1
Growth YoY: —
Industry share: 11%
Top sponsor: Children's Cancer Group, China
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 51–58 of 58 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00458731	Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma	completed	Phase 1	57	National Cancer Institute (NCI)NIH	1	Feb 19, 2014	clinicaltrials
NCT00002970	506U78 in Treating Patients With Refractory Hematologic Cancer	completed	Phase 2	148	National Cancer Institute (NCI)NIH	1	Jul 2, 2013	clinicaltrials